Particle.news

Download on the App Store

Elon Musk exits Trump advisory role, rejects NYT drug allegations

He steps down to resume leadership at his ventures after his 130-day advisory term expired.

Image
Image

Overview

  • Musk concluded his four-month tenure as special advisor for the Department of Government Efficiency at the end of May in line with U.S. limits on such appointments.
  • He publicly disputed a New York Times report that accused him of heavy Ketamine, Ecstasy and psychedelic use during the 2024 campaign, insisting on X that he takes "no drugs."
  • The Times alleges Musk’s Ketamine consumption caused bladder problems and that he traveled with a box of up to 20 pills, while Musk says any Ketamine use was prescription-based and limited to past mental health treatment.
  • Donald Trump said he was unaware of the drug claims and praised Musk as "fantastic," adding that the government efficiency reforms would continue under the DOGE initiative.
  • Musk’s DOGE team reported about $160 billion in savings, though critics note the figure fell far short of the initial two-trillion-dollar goal and drew backlash over deep cuts and layoffs.